The investment will be used to further develop Quantum Nuova, QT Sense’s first commercial product. UMCG, the launching customer, will integrate Quantum Nuova into its Emergency and Acute Care Center for pioneering sepsis diagnostics research.
Sepsis, a life-threatening condition caused by an extreme response to infection, is currently diagnosed based on symptoms that can take hours or even days to manifest. This often leads to delayed treatment, contributing to the loss of many lives. QT Sense’s quantum technology has the potential to detect sepsis within seconds, significantly improving survival rates. Moreover, it offers higher accuracy, reduced complexity, and lower production costs compared to conventional diagnostic techniques.
Ton van ’t Noordende, General Partner at QDNL Participations, an independent venture capital fund specializing in quantum technology, commented: “What stood out about the QT Sense team is their rare combination of deep expertise in quantum sensing and life sciences, paired with a strong capability in product development and commercialization. Exceptional teams like theirs are driving quantum sensing from theoretical research into real-world applications.”
Dr. Deepak H. Veeregowda, co-founder and CEO of QT Sense, added: “While other companies apply quantum sensing to healthcare challenges, their solutions often fall short in spatial resolution and sensitivity, leaving significant gaps in clinical applicability. QT Sense’s single-cell-level detection approach allows for unparalleled precision in disease diagnosis and cellular activity analysis, offering insights that current technologies cannot match.”
QT Sense, a UMCG spin-off, was founded in 2024 by Prof. Dr. Romana Schirhagl, Dr. Deepak Veeregowda, and Hoang Nguyen. QT Sense focuses on revolutionizing biomedical diagnostics through quantum sensing, and is at the forefront of leveraging high-precision quantum technology to improve diagnostics and targeted treatment for complex diseases like cancer and sepsis. QT Sense is one of the top 40 most promising startups in the Netherlands and is currently competing in the Academic Startup Competition.
